Brown Advisory Inc Embecta Corp. Transaction History

Brown Advisory Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$23.07 - $32.77 $2,653 - $3,768	-115 Reduced 1.34%	8,496 $238,000
Q4 2022 Feb 13, 2023	SELL	$25.29 - $35.48 $3,009 - $4,222	-119 Reduced 1.36%	8,611 $217,000
Q3 2022 Nov 14, 2022	BUY	$24.0 - $33.42 $209,520 - $291,756	8,730 New	8,730 $252,000

403

51.2M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $846M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.